Richard F Keep Selected Research

Tamoxifen

1/2016	Effects of Gender and Estrogen Receptors on Iron-Induced Brain Edema Formation.
1/2011	Tamoxifen treatment for intracerebral hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard F Keep Research Topics

Disease

88	Cerebral Hemorrhage 11/2023 - 01/2002
74	Brain Injuries (Brain Injury) 11/2023 - 01/2002
53	Brain Edema (Cerebral Edema) 01/2023 - 02/2002
32	Hematoma 01/2023 - 01/2002
26	Hydrocephalus (Hydrocephaly) 04/2024 - 03/2006
23	Brain Ischemia (Cerebral Ischemia) 08/2023 - 03/2002
19	Hemorrhage 11/2023 - 05/2007
18	Stroke (Strokes) 01/2021 - 02/2004
14	Atrophy 03/2024 - 02/2006
13	Edema (Dropsy) 10/2022 - 02/2002
13	Infarction (Infarctions) 01/2020 - 04/2002
12	Inflammation (Inflammations) 01/2023 - 11/2003
12	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 11/2010
12	Ischemia 11/2019 - 06/2006
10	Iron Overload 11/2023 - 12/2003
10	Neuroinflammatory Diseases 04/2022 - 09/2015
7	Ischemic Stroke 03/2024 - 01/2011
7	Reperfusion Injury 09/2016 - 06/2006
6	Hypoxia (Hypoxemia) 04/2016 - 06/2002
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2014 - 04/2005
5	Hemorrhagic Stroke 09/2022 - 10/2016
5	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 01/2003
5	Glioma (Gliomas) 01/2016 - 04/2006
4	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2002
4	Neoplasms (Cancer) 12/2016 - 01/2008
3	Central Nervous System Cavernous Hemangioma 10/2023 - 11/2015
3	Thrombosis (Thrombus) 01/2022 - 12/2002
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2016 - 08/2014
3	Neurologic Manifestations (Neurological Manifestations) 09/2015 - 02/2004
3	Hyperglycemia 09/2009 - 04/2007
3	Parkinson Disease (Parkinson's Disease) 11/2007 - 01/2005
3	Body Weight (Weight, Body) 07/2007 - 02/2004
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 04/2012
2	Hemolysis 01/2020 - 01/2017
2	Central Nervous System Infections (Central Nervous System Infection) 01/2019 - 10/2014
2	Chordoma 01/2018 - 12/2016
2	Infections 04/2015 - 12/2005
2	Alzheimer Disease (Alzheimer's Disease) 09/2014 - 11/2012
2	Neuroblastoma 09/2014 - 05/2008

Drug/Important Bio-Agent (IBA)

57	IronIBA 04/2024 - 02/2002
40	Thrombin FDA Link 04/2022 - 01/2002
26	Hemoglobins (Hemoglobin)IBA 10/2022 - 02/2002
25	Deferoxamine (Desferal)FDA LinkGeneric 08/2023 - 02/2002
18	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2002
10	Minocycline (Cyclops)FDA LinkGeneric 11/2023 - 03/2009
10	Lipocalin-2IBA 01/2022 - 04/2013
8	Clodronic Acid (Clodronate)IBA 04/2024 - 02/2016
8	Liposomes (Liposome)IBA 04/2024 - 02/2016
7	PeroxiredoxinsIBA 03/2024 - 01/2020
7	Ferritins (Ferritin)IBA 01/2021 - 12/2003
6	CytokinesIBA 04/2022 - 03/2009
6	Heme Oxygenase-1IBA 10/2021 - 12/2003
6	Neuroprotective AgentsIBA 01/2021 - 01/2011
6	Oxygen (Dioxygen)IBA 02/2018 - 06/2006
6	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 06/2006
6	Peptide Hydrolases (Proteases)FDA Link 12/2016 - 10/2006
6	salicylhydroxamic acid (SHAM)IBA 01/2016 - 04/2005
6	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2009 - 01/2002
5	Complement System Proteins (Complement)IBA 04/2022 - 07/2005
5	Chelating AgentsIBA 01/2019 - 02/2002
5	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2011 - 11/2003
4	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2023 - 01/2016
4	Estrogens (Estrogen)FDA Link 01/2022 - 07/2005
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2002
4	EnzymesIBA 01/2019 - 01/2016
4	Thrombin Receptors (Thrombin Receptor)IBA 01/2016 - 04/2002
4	Cefadroxil (Duricef)FDA LinkGeneric 12/2013 - 12/2005
3	Peptides (Polypeptides)IBA 01/2022 - 07/2014
3	AlbuminsIBA 01/2021 - 04/2007
3	SugarsIBA 09/2016 - 01/2011
3	alloseIBA 09/2016 - 01/2011
3	Glutamic Acid (Glutamate)FDA Link 01/2016 - 11/2012
3	Heme (Haem)IBA 01/2016 - 12/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 03/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 03/2006
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013 - 11/2004
3	Mitogen-Activated Protein KinasesIBA 01/2013 - 09/2009
3	Collagenases (Collagenase)FDA Link 06/2011 - 12/2002
3	Oxidopamine (6 Hydroxydopamine)IBA 11/2007 - 01/2005
3	Transferrin (beta 2 Transferrin)IBA 02/2005 - 12/2003
2	Aurintricarboxylic AcidIBA 11/2023 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2012
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2011
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2011
2	Complement C3 (C3 Complement)IBA 01/2021 - 12/2006
2	ChemokinesIBA 01/2020 - 04/2007
2	Penicillin G (Benzylpenicillin)FDA LinkGeneric 01/2019 - 01/2016
2	Hemin (Panhematin)FDA Link 01/2019 - 01/2011
2	Fulvestrant (Faslodex)FDA Link 01/2016 - 07/2005
2	Estrogen ReceptorsIBA 01/2016 - 07/2005
2	ImmunosorbentsIBA 01/2016 - 01/2016
2	Tamoxifen FDA LinkGeneric 01/2016 - 01/2011
2	Antiviral Agents (Antivirals)IBA 04/2015 - 04/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2013 - 01/2008
2	Free Radical ScavengersIBA 01/2012 - 02/2008
2	EdaravoneIBA 01/2012 - 02/2008

Therapy/Procedure

21	Therapeutics 08/2023 - 12/2002
8	Intraventricular Injections 11/2023 - 03/2014
3	Catheters 01/2018 - 07/2002
2	Injections 08/2021 - 01/2021